Kelly Scherer
Adult Health · McKinney, TXNPI 1215972807
Payments from drug & device makers
Across 43 payments — averaging $27.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$208
- Abbott$195
- Alnylam Pharmaceuticals Inc.$122
- AstraZeneca$105
- Lilly USA, LLC$101
- Novo Nordisk$94
- plus $351 from 10 others
What the payments were for
- Food & beverage$1,176100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 5 | $208 |
| Abbott | 3 | $195 |
| Alnylam Pharmaceuticals Inc. | 1 | $122 |
| AstraZeneca | 6 | $105 |
| Lilly USA, LLC | 5 | $101 |
| Novo Nordisk | 5 | $94 |
| Exact Sciences | 4 | $70 |
| Pfizer | 2 | $56 |
| AbbVie | 3 | $56 |
| Astellas Pharma US Inc | 2 | $41 |
| Boehringer Ingelheim | 2 | $33 |
| Merck | 1 | $24 |
| Amgen | 1 | $21 |
| Dexcom, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$148
- AREXVY$130
- AMVUTTRA$122
How this compares
$1,176 in reported general payments places this provider in the 65th percentile of 933 adult health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 32 | $450 |
| Levothyroxine Sodium | 42 | $357 |
| Gabapentin | 20 | $332 |
| Metoprolol Succinate | 14 | $277 |
| Simvastatin | 16 | $250 |
| Losartan Potassium | 20 | $200 |
| Trazodone Hcl | 12 | $146 |
| Amlodipine Besylate | 19 | $129 |
| Metformin Hcl | 12 | $109 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $102 |
| Ciprofloxacin Hcl | 13 | $100 |
| Alprazolam | 17 | $80 |
| Rosuvastatin Calcium | 20 | $46 |
| Prednisone | 21 | $36 |
| Sertraline Hcl | 12 | $12 |
Paid to pharmacies, not to this prescriber.
Other adult health in McKinney
- Mary WilliamsMcKinney$12K
- Trang VoMcKinney$7K
- Misty SheddAllen$863K
- Melodie YoungDallas$700K
- Cynthia BedellPlano$168K
- Elizabeth Wedberg SivamAustin$71K
- Mary SalazarSan Antonio$68K
- Eric KlappholzDallas$44K
- Christin TouchetKingwood$43K
- Yulia LyuboslavskyAustin$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.